COLL stock · IT stock

COLL vs IT

Collegium Pharmaceutical Inc (COLL) versus Gartner Inc (IT) — a side-by-side from cached financials, not a winner call.

Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.

Gartner Inc (IT) is a information technology services company listed on US.

Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.

Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.

COLL currently screens at market cap $1.12B and trailing P/E 16.8. IT currently screens at market cap $11.03B and trailing P/E 16.3.

Not investment advice. Open the COLL and IT stock pages for the full models.

Not investment advice.

Popular Stock Comparisons